CAREDX, INC. Deferred Income Tax Expense (Benefit)
CAREDX, INC. (CDNA) reported Deferred Income Tax Expense (Benefit) of -$149.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-25
- CAREDX, INC. deferred income tax expense (benefit) for the quarter ending 2021-06-30 was -$100.00K.
- CAREDX, INC. deferred income tax expense (benefit) for fiscal 2025 was -$149.00K, a 247.52% decline from fiscal 2024.
- CAREDX, INC. deferred income tax expense (benefit) for fiscal 2024 was $101.00K, a 40.28% increase from fiscal 2023.
- CAREDX, INC. deferred income tax expense (benefit) for fiscal 2023 was $72.00K.
- CAREDX, INC. deferred income tax expense (benefit) for fiscal 2022 was -$278.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|
| 2025-12-31 | -$149.00K 10-K · filed 2026-02-25 | ||
| 2024-12-31 | $101.00K 10-K · filed 2026-02-25 | ||
| 2023-12-31 | $72.00K 10-K · filed 2026-02-25 | ||
| 2022-12-31 | -$278.00K 10-K · filed 2025-02-28 | ||
| 2021-12-31 | -$1.38M 10-K · filed 2024-02-28 | ||
| 2021-06-30 | -$100.00K 10-Q · filed 2021-07-29 | -$400.00K 10-Q · filed 2021-07-29 | |
| 2020-12-31 | -$1.14M 10-K · filed 2023-02-27 | ||
| 2019-12-31 | -$1.49M 10-K · filed 2022-02-24 | ||
| 2018-12-31 | -$1.60M 10-K · filed 2021-02-24 | ||
| 2017-12-31 | -$1.85M 10-K · filed 2020-02-28 | ||
| 2016-12-31 | -$1.70M 10-K · filed 2019-03-06 | ||
| 2015-12-31 | $0.00 10-K · filed 2018-03-22 | ||
| 2014-12-31 | -$1.50M 10-K · filed 2017-04-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |